Related Experiment Video
Updated: Jun 13, 2026
A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
Published on: January 12, 2018
Patient Perspectives in Cardiovascular Research: A Qualitative Study of Barriers, Trust, and Strategies for Inclusive
Stephanie Niño de Rivera1, Niurka Suero-Tejeda2, Rhonda Monroe3
1Weill Cornell Medicine, New York, NY (S.N.d.R., B.R., M.F.L.G.).
Insights
To improve cardiovascular clinical trial diversity, patient feedback highlights the need for clear communication and trust. Addressing barriers like complex language and historical mistrust is key for inclusive recruitment strategies.
Area of Science:
- Cardiovascular Research
- Health Equity
- Clinical Trial Recruitment
Background:
- Cardiovascular disease disproportionately affects women, Black, and Hispanic patients.
- These populations are underrepresented in clinical trials.
- Understanding patient perspectives is crucial for inclusive recruitment.
Purpose of the Study:
- To identify barriers and facilitators to clinical trial participation among underrepresented groups.
- To inform inclusive recruitment strategies for the RECHARGE trial.
- To enhance representation in cardiovascular research.
Main Methods:
- Qualitative study using focus groups and interviews with Black and Hispanic adults.
- Interviews guided by the Social-Ecological Model.
- Analysis using directed content analysis and constant comparative approach.
Main Results:
- Barriers included complex materials, medical jargon, and mistrust of randomization.
- Societal barriers included limited outreach and lack of culturally appropriate materials.
- Facilitators included trust in providers, family involvement, and clear, multilingual communication.
Conclusions:
- Transparent, accessible communication and trust are vital for increasing representation.
- Engaging trusted healthcare providers and community outreach are critical for equity.
- Tailoring recruitment strategies to patient needs can advance cardiovascular research.
Background:
Women, Black, and Hispanic patients bear a disproportionate burden of cardiovascular disease yet remain underrepresented in clinical trials. Understanding patient perspectives is essential to developing inclusive recruitment strategies in cardiovascular research.
Methods:
The RECHARGE trial (Revascularization Choices Among Underrepresented Groups Evaluation) is an ongoing comparative effectiveness study comparing percutaneous coronary intervention and coronary artery bypass grafting among women, Black, and Hispanic patients. To inform recruitment strategies, we conducted a qualitative study using in-person and virtual focus groups and semistructured interviews. Participants were US adults who identified as Black or Hispanic and had a history of percutaneous coronary intervention, coronary artery bypass grafting, or advanced cardiovascular disease. Interviews were guided by the Social-Ecological Model and analyzed using directed content analysis with a constant comparative approach.
Results:
The sample included 42 participants (35 women, 7 men); 29 identified as Hispanic and 13 as Black. Barriers and facilitators to trial participation spanned multiple levels of the Social-Ecological Model. At the individual and interpersonal levels, barriers included complex study materials, excessive medical jargon, and mistrust of randomization, with concerns about being assigned a less effective treatment. At community and societal levels, participants cited limited recruitment outreach, lack of culturally and linguistically appropriate materials, and mistrust stemming from historical research injustices. Facilitators included trust in healthcare providers, reassurance regarding treatment appropriateness, and involvement of family or support systems. At the community and societal levels, accessible, visual, and multilingual materials were highlighted to support understanding. Participants emphasized the value of plain language, visual, and multilingual materials, adequate time for shared decision-making, and transparent communication about study goals.
Conclusions:
Increasing representation of underrepresented populations in cardiovascular trials requires transparent, accessible communication and trust-centered recruitment strategies. Leveraging trusted healthcare providers and community-based outreach is critical to advancing equity in cardiovascular research.
Registration:
URL: https://www.clinicaltrials.gov; Unique identifiers: NCT06399705 and NCT06399692.
Related Concept Videos
01:11Clinical Trials: Overview
01:16Clinical Trials
There are four phases in a clinical trial. A phase one...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:23Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
01:26Longitudinal Studies
01:15Bioavailability Study Design: Healthy Subjects Versus Patients